Cargando…
Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis
BACKGROUND: Macrophage activation syndrome (MAS) is a severe complication of autoimmune diseases with high mortality. We report the effectiveness of baricitinib as an option for the maintenance therapy in MAS secondary to nodular panniculitis. CASE SUMMARY: A 24-year-old female came to our hospital...
Autores principales: | Yi, Guanqun, Huang, Zhengping, Huang, Zhixiang, Wang, Yunqing, Deng, Weiming, Zheng, Shaoling, Li, Tianwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298961/ https://www.ncbi.nlm.nih.gov/pubmed/35874753 http://dx.doi.org/10.3389/fimmu.2022.914265 |
Ejemplares similares
-
Nodular Panniculitis with Hemophagocytic Lymphohistiocytosis
por: Liu, Huan, et al.
Publicado: (2018) -
Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis
por: Liu, Meng, et al.
Publicado: (2019) -
Subcutaneous Panniculitis-Like T Cell Lymphoma Mimicking Early-Onset Nodular Panniculitis
por: Shen, Guifen, et al.
Publicado: (2016) -
Implementation of telemedicine for knee osteoarthritis: study protocol for a randomized controlled trial
por: Huang, Zhengping, et al.
Publicado: (2018) -
Nodular panniculitis in a cat with high alpha tocopherol concentration in serum
por: Steffl, Martin, et al.
Publicado: (2020)